Great Novel Therapeutics Biotech & Medicals - PE Ratio

The PE Ratio as of October 2026 (TTM) for Great Novel Therapeutics Biotech & Medicals (7427.TWO) is -25.31

According to Great Novel Therapeutics Biotech & Medicals’s latest financial reports and current stock price. The company's current PE Ratio is -25.31. This represents a change of 222.65% compared to the average of -7.84 of the last 4 quarters.

Great Novel Therapeutics Biotech & Medicals (7427.TWO) Historical PE Ratio (quarterly & annually)

How has 7427.TWO PE Ratio performed in the past?

The mean historical PE Ratio of Great Novel Therapeutics Biotech & Medicals over the last ten years is -21.69. The current -25.31 PE Ratio has changed 11.57% with respect to the historical average. Over the past ten years (40 quarters), 7427.TWO's PE Ratio was at its highest in in the December 2025 quarter at -6.49. The PE Ratio was at its lowest in in the June 2023 quarter at -24.95.

Great Novel Therapeutics Biotech & Medicals (7427.TWO) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Great Novel Therapeutics Biotech & Medicals PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Great Novel Therapeutics Biotech & Medicals (7427.TWO) Average PE Ratio

How has 7427.TWO PE Ratio performed in the past?

The current PE Ratio of Great Novel Therapeutics Biotech & Medicals (7427.TWO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Great Novel Therapeutics Biotech & Medicals (7427.TWO) PE Ratio vs. Peers

How is 7427.TWO’s PE Ratio compared to its peers?

Great Novel Therapeutics Biotech & Medicals’s PE Ratio is less than GlycoNex Incorporation (-9.06), less than Lukas Biomedical Inc. (-8.43), greater than Pell Bio-Med Technology Co., Ltd. (-118.12), less than PharmaEngine, Inc. (15.07), less than Medigen Biotechnology Corp. (-19.84), less than LAUNXP Biomedical Co., Ltd (-1.93), less than Acepodia, Inc. (-12.09), less than Formosa Pharmaceuticals, Inc. (0),

Build a custom stock screener for Great Novel Therapeutics Biotech & Medicals (7427.TWO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Great Novel Therapeutics Biotech & Medicals using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Great Novel Therapeutics Biotech & Medicals (7427.TWO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Great Novel Therapeutics Biotech & Medicals or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.